Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
VHAQ.WS was delisted on the 23rd of October, 2023.
31 hedge funds and large institutions have $9.9M invested in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
6% more capital invested
Capital invested by funds: $9.37M → $9.9M (+$539K)
6% less funds holding
Funds holding: 33 → 31 (-2)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$1.09K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$772 |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$279 |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$99 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$12.6K |
| 2 |
CAC
Cowen and Company
New York
|
-$3.23K |
| 3 |
VF
Virtu Financial
New York
|
-$1K |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$297 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7 |
VHAQ.WS Hedge Fund Activity: Q3 2022 in Review
31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) for Q3 2022, worth a combined $9.9M — up 5.8% from $9.37M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of VHAQ.WS and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $1.09K. The largest seller was Picton Mahoney Asset Management, cutting an estimated $12.6K.
- 31 institutional investors held Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share (VHAQ.WS) as of Q3 2022, down from 33 in Q2 2022.
- Funds reported $9.9M of Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share stock for Q3 2022, up 5.8% quarter-over-quarter.
- 1 fund opened new Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share positions in Q3 2022 and 3 closed out, a net change of -2 holders.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share buyer in Q3 2022 was Saba Capital Management, an estimated $1.09K added.
- The largest Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share seller in Q3 2022 was Picton Mahoney Asset Management, an estimated $12.6K sold.
Based on aggregated 13F filings for Q3 2022.